Monopar Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -11,074 | -1,574,902 | -1,788 | -1,723 |
EBIT | -1,574 | -3,577 | -3,446 | |
Net Income | -10,925 | -1,304,276 | -1,715 | -1,641 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,998 | -1,073 | -1,676 | -1,655 |
Cash | 45,816 | 6,020 | 6,119 | 7,807 |
Basic Shares | 37,902 | 35,203 | 17,514 | 15,979 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -16,161,721 | 429 | -10,515 | -9,079 |
EBIT | -8,402 | -10,536 | -9,127 | |
Net Income | -15,586,419 | -8,402 | -10,494 | -9,079 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,404,139 | -7,858 | -7,228 | -7,317 |
Cash | 45,816 | 7,266 | 8,186 | 20,303 |
Basic Shares | 37,902 | 14,511 | 12,718 | 12,472 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$2.75 |
2024-09-30 | -$0.37 |
2024-06-30 | -$0.50 |
2024-03-31 | -$0.10 |
